Qube Research & Technologies (QRT)
IDNA icon

Qube Research & Technologies (QRT)’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Sell
2
-293
-99% -$8.79K ﹤0.01% 3402
2026
Q1 		$8.57K Sell
295
-35
-11% -$1.02K ﹤0.01% 3344
2025
Q4 		$8.64K Buy
+330
New +$8.49K ﹤0.01% 3464
2022
Q3 		– Sell
-56
Closed -$2K – 2729
2022
Q2 		$2K Buy
+56
New +$1.67K ﹤0.01% 2382

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IDNA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 99% in Q2 2026, selling an estimated $8.79K and leaving 2 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #3402.

Qube Research & Technologies (QRT) first reported a position in IDNA in Q2 2022 and has held it in 4 quarters since. The position peaked at $8.64K in Q4 2025. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 2 shares of iShares Genomics Immunology and Healthcare ETF worth $68 as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 293 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $8.79K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3402 holding.
  • Qube Research & Technologies (QRT) first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2022 and has held it in 4 quarters since.
  • Qube Research & Technologies (QRT)'s iShares Genomics Immunology and Healthcare ETF position peaked at $8.64K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.